Voloridge Investment Management
MIRM icon

Voloridge Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Voloridge Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.62M Sell
104,099
-193,851
-65% -$18.2M 0.04% 516
2025
Q4 		$23.5M Sell
297,950
-91,624
-24% -$6.58M 0.08% 317
2025
Q3 		$28.6M Buy
389,574
+371,999
+2,117% +$23.6M 0.1% 251
2025
Q2 		$894K Sell
17,575
-57,430
-77% -$2.56M ﹤0.01% 1040
2025
Q1 		$3.38M Sell
75,005
-96,532
-56% -$4.55M 0.01% 877
2024
Q4 		$7.09M Sell
171,537
-85,242
-33% -$3.55M 0.03% 675
2024
Q3 		$10M Buy
+256,779
New +$10.2M 0.04% 587
2024
Q1 		– Sell
-70,441
Closed -$2.08M – 1280
2023
Q4 		$2.08M Sell
70,441
-173,550
-71% -$5.25M 0.01% 822
2023
Q3 		$7.71M Buy
+243,991
New +$6.68M 0.04% 517
2023
Q1 		– Sell
-24,989
Closed -$487K – 1515
2022
Q4 		$487K Buy
+24,989
New +$494K ﹤0.01% 1280

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Voloridge Investment Management's MIRM Position: Q1 2026 in Review

Voloridge Investment Management reduced its Mirum Pharmaceuticals (MIRM) stake by 65% in Q1 2026, selling an estimated $18.2M and leaving 104,099 shares worth $9.62M. The position accounts for 0.04% of the portfolio, ranked #516.

Voloridge Investment Management first reported a position in MIRM in Q4 2022 and has held it in 10 quarters since. The position peaked at $28.6M in Q3 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Voloridge Investment Management held 104,099 shares of Mirum Pharmaceuticals worth $9.62M as of Q1 2026.
  • Voloridge Investment Management sold 193,851 Mirum Pharmaceuticals shares in Q1 2026, an estimated $18.2M.
  • Mirum Pharmaceuticals made up 0.04% of Voloridge Investment Management's portfolio in Q1 2026, its #516 holding.
  • Voloridge Investment Management first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
  • Voloridge Investment Management's Mirum Pharmaceuticals position peaked at $28.6M in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.